AHA provides feedback to the Food and Drug Administration on regulatory considerations for generative artificial intelligence (GenAI)-enabled medical devices.
AHA Policy Letters: Supporting AI Innovation while Promoting Patient Safety
Latest
The American Hospital Association input on the FDA report on the risks and benefits to health and safety that are associated with non-device software as required under Section 3060 of the 21st Century Cures Act.
AHA responds to CMS RFI on regulations to combat fraud, waste and abuse (CRUSH).
The American Hospital Association provides comments on the Health and Human Services request for information on accelerating the adoption and use of artificial intelligence (AI) as part of clinical care.
The AHA supports AI policy frameworks that balance flexibility to drive market-based innovations with appropriate safeguards to protect privacy and patient safety.
The American Hospital Association (AHA) provides comments on the Office of Science and Technology Policy (OSTP) request for information regarding regulatory reform on artificial intelligence (AI).
The AHA responds to Representative Bera's request for information regarding the current state of artificial intelligence in the health care sector.